Current Management of Patients With Diverticulosis and Diverticular Disease: A Survey From the 2nd International Symposium on Diverticular Disease.

Abstract

BACKGROUND:

Management of diverticular disease (DD) remains a point of debate.

GOALS:

To investigate the current opinion of participants of the 2nd International Symposium on Diverticular Disease, on real-life management of patients with DD of the colon.

STUDY:

Twelve questions were aimed at the diagnosis, treatment, and management options for diverticulosis and symptomatic DD.

RESULTS:

In total, 115 surveys from 8 European Countries were filled out. High fiber diet was widely prescribed in diverticulosis (59.1%). Probiotics (25%) were the most frequent prescribed drug, whereas 29.8% of participants did not prescribe any treatment in diverticulosis. Colonoscopy was frequently prescribed in symptomatic patients (69.3%), whereas 72.9% of participants did not prescribe any instrumental tool in their follow-up. Rifaximin, probiotics, and mesalazine were the most frequent prescribed drugs both in symptomatic patients (28.1, 14.9%, and 11.4%, respectively) and to prevent recurrence of the disease (42.5%, 12.4%, and 28.2%, respectively). With respect to laboratory exams, 57.9% of participants prescribed them during follow-up. The majority of participants (64.9%) managed suspected acute diverticulitis at home. Rifaximin, probiotics, and mesalazine were the most frequent prescribed drugs to prevent recurrence of the disease (32.2%, 13.2%, and 11.4%, respectively), whereas 25.4% of participants did not prescribe any drugs. Finally, no differences were found among gastroenterologists, surgeons, and general practitioners in managing this disease.

CONCLUSIONS:

This surveys shows that current management of DD is similar between different medical specialities, generally in line with current literature.

• Authors: Antonio Tursi, Marcello Picchio, Walter Elisei, Francesco Di Mario, Carmelo Scarpignato, Giovanni Brandimarte
• Journal: Journal of clinical gastroenterology (J Clin Gastroenterol) Vol. 50 Suppl 1 Pg. S97-S100 (10 2016) ISSN: 1539-2031 [Electronic] United States
• PMID: 27622380 (Publication Type: Journal Article)

Chemical References

• Anti-Infective Agents
• Anti-Inflammatory Agents, Non-Steroidal
• Rifamycins
• Mesalamine
• Rifaximin

Topics

• Anti-Infective Agents (therapeutic use)
• Anti-Inflammatory Agents, Non-Steroidal (therapeutic use)
• Colonoscopy (statistics & numerical data)
• Congresses as Topic
• Disease Management
• Diverticular Diseases (therapy)
• Diverticulosis, Colonic (therapy)
• Europe
• Gastroenterologists (statistics & numerical data)
• General Practitioners (statistics & numerical data)
• Humans
• Mesalamine (therapeutic use)
• Practice Patterns, Physicians' (statistics & numerical data)
• Probiotics (therapeutic use)
• Rifamycins (therapeutic use)
• Rifaximin
• Surgeons (statistics & numerical data)
• Surveys and Questionnaires